Global Healthcare Distribution Market
Healthcare distribution is defined as the concept of providing different care services such as drugs, diagnostic test and other facilities to the patients. Healthcare system is very essential as it helps people to stay healthy. Healthcare distribution classified into some common types such as Pharmaceutical product distribution, medical device distribution service, and biopharmaceutical distribution services. Today, healthcare industry is using many different technologies & developments to expand healthcare industry and to offer better facilities to the patients.
Market Drivers
The increase in prevalence of chronic diseases is the one of the prominent factors expected to boost the global healthcare distribution market growth. For instance, as per the information provided by the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research & Clinical Practice, in September 2019, around 463 million people are suffering from diabetes in 2019 across the globe and the number is expected to reach approximately 578 million by 2030 and approximately 700 million by 2045.
Furthermore, increase in geriatric population across the globe as well as the growing preference for value-based healthcare are expected to propel the global healthcare distribution market growth. For instance, as per the information provided by the World Health Organization (WHO), around 703 million persons aged 65 years or over in the world in the year2019. The number of older persons is anticipated to double to 1.5 billion by 2050. Moreover, the increase in investment in research and development activities and the growing launch of new drugs in healthcare industry is expected to contribute the growth of global healthcare distribution market throughout the forecast period. In addition, growing technological advancements along with the subsequent growth in track and trace solutions in the healthcare distribution industry are further accelerating the growth of the market.
Know more about this report: request for sample pages
Market Restraints
Stringent government rules and regulations related to the drug development is the major restraint which may hamper the growth of global healthcare distribution market growth during this forecast period. Further, high cost of drug is expected to hinder the global healthcare distribution market growth.
Market Segmentation
The Global Healthcare Distribution Market is segmented into type such as Pharmaceutical Product Distribution Services, Medical Device Distribution Services, and Biopharmaceutical Product Distribution Services. The Pharmaceutical product distribution service segment dominated the global healthcare distribution market, due to the increase in demand for OTC and generic drugs from patients as well as the increase in expenditure on pharmaceutical research and development activities will positively influence the segment growth. Also, growing production of pharmaceutical formulations, and outsourcing of pharmaceutical manufacturing to Asian countries is further boosting the segment growth.
On the basis of end user market is segmented into Retail Pharmacies, Hospital Pharmacies, and Others. Retail pharmacies dominated the market growth due to the implementation of programs to guarantee accessible healthcare for people in the developed countries including United States, which subsequently increases the quantity of prescription. The retail pharmacies deal with large volume of prescriptions daily, which expected to support the growth of the segment.
Regional Analysis
The Global Healthcare Distribution Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
The North America region dominated the healthcare distribution market due to its strong foothold in healthcare sector as well as rapid adoption of new & advanced technologies in the market. The market is also anticipated to maintain its dominance throughout the forecast period, owing to its continuous involvement and development in healthcare industry.
Moreover, the Asia Pacific market is estimated to grow at the highest CAGR over the forecast period due to the increasing regulatory requirements in the healthcare industries of several APAC countries to maintain compliance with good manufacturing & distribution practices and the growing number of pharmaceutical & biotechnology companies in this region. China & India are the fastest-growing markets in the region majorly due to the expanding pharmaceutical industries in these countries and the implementation of stringent regulations to improve the quality & reliability of pharmaceutical drugs.
Key Players
The prominent players operating in the global healthcare distribution market are Cardinal Health, AmerisourceBergen Corporation, McKesson Corporation, Owens & Minor, Inc., KeySource Medical, Inc., Morris and Dickson Co., LLC, Rochester Drug Cooperative, Inc., Smith Drug Company, Henry Schein Inc., Patterson Companies Inc., etc. Some of the key developments in the healthcare industry which is expected to boost the global healthcare distribution market growth. For instance, in May 2019, McKesson has renovated its CVS Health allocation contract by 2023. The aim of this renovation is to reinforce its market position, the company focuses on innovation in current goods & solutions. Furthermore, in April 2019, Cardinal Health partnered with PANTHERx Specialty Pharmacy, USA to strengthen its cell & gene therapy facilities by co-ordinated distributed suite of specialty facilities, third-party logistics service, and specialty pharmacy delivery services.
Market Taxonomy
By Type
By Distribution Channel
By Region
Key Questions Addressed by the Report
Global Healthcare Distribution Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Healthcare Distribution Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Healthcare Distribution Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Healthcare Distribution Market Share Analysis, By Type
5.3 Global Healthcare Distribution Market Size and Forecast, By Type
5.3.1 Pharmaceutical Product Distribution Services
5.3.2 Medical Device Distribution Services
5.3.3. Biopharmaceutical Product Distribution Services
6 Global Healthcare Distribution Market, By Distribution Channel
6.1 Y-o-Y Growth Comparison, By Distribution Channel
6.2 Global Healthcare Distribution Market Share Analysis, By Distribution Channel
6.3 Global Healthcare Distribution Market Size and Forecast, By Distribution Channel
6.3.1 Retail Pharmacies
6.3.2 Hospital Pharmacies
6.3.3 Others
7Global Healthcare Distribution Market, By Region
7.1 Global Healthcare Distribution Market Share Analysis, By Region
7.2 Global Healthcare Distribution Market Share Analysis, By Region
7.3 Global Healthcare Distribution Market Size and Forecast, By Region
8North America Healthcare Distribution Market Analysis and Forecast (2020 – 2027)
8.1 Introduction
8.2 North America Healthcare Distribution Market Share Analysis, By Type
8.3 North America Healthcare Distribution Market Size and Forecast, By Distribution Channel
8.4 North America Healthcare Distribution Market Size and Forecast, By Country
8.4.1 U.S
8.4.2 Canada
8.4.3 Mexico
9Europe Healthcare Distribution Market Analysis and Forecast (2020 – 2027)
9.1 Introduction
9.2 Europe Healthcare Distribution Market Share Analysis, By Type
9.3 Europe Healthcare Distribution Market Size and Forecast, By Distribution Channel
9.4 Europe Healthcare Distribution Market Size and Forecast, By Country
9.4.1 Germany
9.4.2 France
9.4.3 UK
9.4.4. Rest of Europe
10Asia Pacific Healthcare Distribution Market Analysis and Forecast (2020 – 2027)
10.1 Introduction
10.2 Asia Pacific Healthcare Distribution Market Share Analysis, By Type
10.3 Asia Pacific Healthcare Distribution Market Size and Forecast, By Distribution Channel
10.4 Asia Pacific Healthcare Distribution Market Size and Forecast, By Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4. Rest of Asia Pacific
11Latin America Healthcare Distribution Market Analysis and Forecast (2020 – 2027)
11.1 Introduction
11.2 Latin America Healthcare Distribution Market Share Analysis, By Type
11.3 Latin America Healthcare Distribution Market Size and Forecast, By Distribution Channel
11.4 Latin America Healthcare Distribution Market Size and Forecast, By Country
12Middle East Healthcare Distribution Market Analysis and Forecast (2020 – 2027)
12.1 Introduction
12.2 Middle East Healthcare Distribution Market Share Analysis, By Type
12.3 Middle East Healthcare Distribution Market Size and Forecast, By Distribution Channel
12.4 Middle East Healthcare Distribution Market Size and Forecast, By Country
13Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 Cardinal Health
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2 AmerisourceBergen Corporation
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3 McKesson Corporation
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Owens & Minor, Inc
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 KeySource Medical, Inc
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Morris and Dickson Co., LLC
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Rochester Drug Cooperative, Inc
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Smith Drug Company
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Henry Schein Inc
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Patterson Companies Inc
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies